Skip to content

The Plant-Derived Compound Resveratrol in Brain Cancer: A Review

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023272/

This study, from January 2020, reviewed the research on Resveratrol and brain cancer to date and found that there are promising results that warrant further study.

Resveratrol exhibits a number of tumor-inhibiting properties, alleviates tumor resistance to Temozolomide (Temodar), and crosses the blood-brain barrier.

Share on facebook
Share on email
Share on twitter
Share on linkedin

More on Resveratrol

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments